Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D05BCA
|
|||
| Former ID |
DIB007656
|
|||
| Drug Name |
MX-4509
|
|||
| Synonyms |
17alpha-Estradiol; 57-91-0; Alfatradiol; Epiestradiol; 17-alpha-Estradiol; 3,17-Dihydroxyestratriene; 17a-estradiol; Estradiol-17alpha; Epiestrol; 17-Epiestradiol; Estra-1,3,5(10)-triene-3,17alpha-diol; 17alpha estradiol; NSC 20293; UNII-3VQ38D63M7; Alfatradiol [INN]; Oestradiol-17alpha; 17alpha-Oestradiol; Estradiol, 17alpha-; CHEBI:17160; VOXZDWNPVJITMN-SFFUCWETSA-N; 3VQ38D63M7; 17-epi-Estradiol; Alfatradiol (INN); Oestradiol-17-alpha; MITO-4509; Parkinsons therapeutics, MitoKor; Drug screening (Parkinsons), MitoKor; Estrogen analogs (Parkinsons), Mitokor
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Neurological disorder [ICD-11: 6B60] | Discontinued in Phase 1 | [1] | |
| Company |
MitoKor; Migenix
|
|||
| Structure |
 |
Download2D MOL |
||
| Formula |
C18H24O2
|
|||
| Canonical SMILES |
CC12CCC3C(C1CCC2O)CCC4=C3C=CC(=C4)O
|
|||
| InChI |
1S/C18H24O2/c1-18-9-8-14-13-5-3-12(19)10-11(13)2-4-15(14)16(18)6-7-17(18)20/h3,5,10,14-17,19-20H,2,4,6-9H2,1H3/t14-,15-,16+,17-,18+/m1/s1
|
|||
| InChIKey |
VOXZDWNPVJITMN-SFFUCWETSA-N
|
|||
| CAS Number |
CAS 57-91-0
|
|||
| PubChem Compound ID | ||||
| ChEBI ID |
CHEBI:17160
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800020680) | |||
| REF 2 | Androgen antagonistic effect of estramustine phosphate (EMP) metabolites on wild-type and mutated androgen receptor. Biochem Pharmacol. 1998 May 1;55(9):1427-33. | |||
| REF 3 | Review of the effects of 17alpha-estradiol in humans: a less feminizing estrogen with neuroprotective potential. Article first published online: 9 FEB 2009. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.